Monogram Orthopedics

Monogram Orthopedics

Monogram Orthopedics | Online Public Offering.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

Valuation: €0.0

143.1x EV/Revenue

-9.1x EV/EBITDA

round
N/A

€0.0

round
N/A

€0.0

round
*

$177m

Acquisition
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2019202020212022202320242026
Revenues0000000000000000000000000000
EBITDA0000000000000000000000000000
% EBITDA margin--(1577 %)-(5464 %)--
Profit0000000000000000000000000000
% profit margin--(1881 %)-(3766 %)--
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue--840 %-2900 %--

Source: Company filings or news article, Equity research estimates

Notes (0)
More about Monogram Orthopedics
Made with AI
Edit

Monogram Orthopaedics Inc. (NASDAQ: MGRM) is a medical technology company based in Austin, TX, specializing in reconstructive joint procedures and surgical robotics. The company focuses on developing advanced robotic systems to improve the precision and outcomes of joint surgeries. Monogram serves healthcare providers, including hospitals and surgical centers, by offering cutting-edge robotic solutions that enhance surgical accuracy and efficiency. Operating in the medical technology market, Monogram's business model revolves around the development, commercialization, and sale of its proprietary surgical robots. The company generates revenue through the sale of these robots and related services. Recently, Monogram achieved a significant milestone by delivering its first surgical robot to a major global distributor, marking the start of its commercial revenue stream. The company is currently in the Verification Phase of its next-generation autonomous surgical robotic system, which involves extensive testing to ensure optimal performance. With a cash runway of approximately 15 months as of September 2023, Monogram is strategically positioned to advance its technology and expand its market presence.

Keywords: surgical robotics, reconstructive joint procedures, medical technology, healthcare providers, robotic systems, surgical accuracy, commercialization, revenue generation, autonomous robots, market expansion.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads